Maximum quantity allowed is 999
请选择数量
CAS RN: 191217-81-9 | 产品编码: P2073
Pramipexole Dihydrochloride Monohydrate
×
![]()
×
| 产品编码 | P2073 |
| 纯度/分析方法 | >98.0%(HPLC)(N) |
| 分子式/分子量 | C__1__0H__1__7N__3S·2HCl·H__2O = 302.26 |
| 外观与形状（20°C） | 固体 |
| 储存温度 | 室温 (15°C以下阴凉干燥处) |
| 包装和容器 | 100MG-Glass Bottle with Plastic Insert （查看图片）, 1G-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 191217-81-9 |
| 相关CAS RN | 104632-25-9&104632-26-0 |
| Reaxys-RN | 14116907 |
| PubChem物质ID | 253659970 |
| Merck Index (14) | 7705 |
| MDL编号 | MFCD02183927 |
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Specific rotation [a]20/D | -65.0 to -71.0 deg(C=1,MeOH) |
| Water | 5.0 to 7.0 % |
物性（参考值）
| 熔点 | 290 °C(dec.) |
| 比旋光度 [α]D | -67° (C=1,MeOH) |
| 水溶性 | 可溶 |
| 溶解性（可溶于） | 甲醇 |
| 溶解性（不溶于） | 二氯甲烷 |
GHS
| 象形图 |
|
| 信号词 | Warning |
| 危险性说明 | H302 : Harmful if swallowed. H336 : May cause drowsiness or dizziness. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P271 : Use only outdoors or in a well-ventilated area. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P403 + P233 : Store in a well-ventilated place. Keep container tightly closed. P405 : Store locked up. |
相关法规
| RTECS# | DL3375000 |
运输信息
| HS编码* | 2934.20-000 |
应用
A Dopamine D3 Receptor Agonist, Pramipexole
Pramipexole [P2879] and its dihydrochloride are non-ergot dopamine agonists with high relative specificity and full intrinsic activity at the D2 subfamily (D2, D3, D4) of dopamine receptors. The affinity for the D3 receptor subtype is the highest. Specifically, pramipexoles have selective affinity for the D2 subfamily (D2, D3, D4), with a 7-10 fold greater affinity for D3 than for D2 receptor subtypes; affinity for the D4 receptor subtype is 17-fold less than for D3 receptors. In clinical, the dihydrochloride is used for the treatment of Parkinson's disease. Although the precise mechanism of action is unknown, it is believed to be related to its ability to stimulate dopamine receptors in the striatum. (The product is for research purpose only.)
References
- Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors
- Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist
- Mechanisms of action of pramipexole: Effects on receptors
- M. Dziedzicka-Wasylewska, F. Ferrari, R. D. Johnson, J. Mierau, Z. Rogoz, G. Skuza, P. Sokoloff, Rev. Contemp. Pharmacother. 2003, 12, 1.
- Mechanisms of action of pramipexole: putative neuroprotective effects
- J. P. Bennett Jr., P. M. Carvey, T. R. Hinds, R. D. Johnson, W. Le, W. Phillips, V. H. Sethy, F. F. Vincenzi, M. B. H. Youdim, Rev. Contemp. Pharmacother. 2003, 12, 33.
- Pharmacokinetic evaluation of pramipexole
参考文献
TCIMail
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。